![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-cce2f8ff874ad17bdadeb452a794822ab5b400e90531fa9e3eceb5d9a54af247.jpg)
Transcutaneous Bilirubin Measurements in Newborns: Clinical and Cost-Effectiveness, and Guidelines
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.